Nitric oxide and cardiovascular disease

Postgraduate Medical Journal

Volumn 73, Issue 864, 1997, Pages 630-634

  McIntyre, Martin ^a   Dominiczak, Anna F ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Hypertension; Nitric oxide

Indexed keywords

CORONARY VASODILATING AGENT; ESTROGEN; NITRIC OXIDE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; ENDOTHELIUM; ESSENTIAL HYPERTENSION; GENE THERAPY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PATHOGENESIS; SHORT SURVEY; SMOKING;

EID: 0030712983     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.864.630     Document Type: Short Survey

References (38)

1. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 228: 373-6.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987; 327: 524-6.
3. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature 1988; 333: 664-6.
5. Förstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isoenzymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-31.
6. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circulat Res 1994; 74: 349-53.
7. Tolins JP, Palmer RM, Moncada S, Raij L. Role of endothelium-derived relaxing factor in regulation of renal haemodynamic responses. Am J Physiol 1990; 258: H655-62.
8. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
9. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-33.
10. Treasure CB, Manoukian SV, Klein JL, et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res 1992; 71: 776-81.
11. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo blunted response in hypertension. Circulation 1990; 81: 176-27.
12. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-31.
13. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-40.
14. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B, Safar M. Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol 1990; 258: H1004-11.
15. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension 1995; 25: 1202-11.
16. Nakaki T, Hishikawa K, Suzuki H Saruta T, Kato R. L-Arginine induced hypotension. Lancet 1990; 336: 696.
17. Ribeiro MO, Antunes E, de-Nucci G, Lovisolo SM, Zata R. Chronic inhibition of nitric oxide synthase. A new model of arterial hypertension. Hypertension 1992; 20: 298-303.
18. Arnal JF, el-Amrani AI, Chatellier G, Menard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993; 22: 380-7.
19. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11: 375-80.
20. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-42.
21. Cooke JP, Tsao PS. Is nitric oxide an endogenous antiatherogenic molecule? Arterioscler Thromb 1994; 14: 653-5.
22. Rubbo H, Parthasarathy S, Barnes S, Kirk M, Kalyanaraman B, Freeman BA. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidised lipid derivatives. Arch Biochem Biophys 1995; 324: 15-25.
23. Galle J, Busse R, Bassenge E. Effects of native and oxidised low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb 1991; 11: 198-203.
24. O'Hara Y, Peterson TE, Harrison DG. Hypercholesterolaemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-51.
25. Moro MA, Darley-Usmar VM, Goodwin DA, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994; 91: 6702-6.
26. Candipan RC, Wang BY, Buitrago R, Tsao PS, Cooke JP. Regression or progression: dependency on vascular nitric oxide. Arterioscler Thromb Vase Biol 1996; 16: 44-50.
27. Drexler H, Zeiher AM, Heinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-50.
28. Gryglewski RJ, Grodzinska L, KostkaTrabka E, et al. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease. Wien Klin Wochenschr 1996; 108: 111-6.
29. Wennmalm A, Edlund A, Granstrom EF, Wiklund O. Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesteroaemia. Atherosclerosis 1995; 118: 223-31.
30. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-5.
31. Ignarro LJ, Lipton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-49.
32. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861-7.
33. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 1994; 205: 905-10.
34. Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995; 214: 847-55.
35. Smith SS. Female sex steroid hormones: from receptors to networks to performance. Prog Neurobiol 1994; 44: 55-86.
36. Venema RC, Nishida K, Alexander RW, Harrison DG, Murphy TJ. Organisation of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1994; 3: 413-20.
37. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 1995; 92: 5-8.
38. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-41.